Asia in counterfeits chase; disposables penetrate high-potency API-making;

> Korea has seen a 23-fold rise in counterfeit impotence drugs over the past five years, with the majority coming from China. Article

> China's State Food and Drug Administration has provided the names of 33 fake drugs to help provincial and national authorities investigate counterfeiting. Article

> In five to ten years, disposable components may account for more than 90 percent of equipment used to make highly potent APIs. Article

> Shire will remove low-blood pressure drug ProAmatine from the market, rather than conduct the additional clinical trials the FDA has requested. Article

> Cannabis Science has licensed Denver-based RockBrook to manufacture and sell its medical marijuana formulations and delivery systems. Release

Special Report: The top counterfeit drugs. Read >>

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.